search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Improving treatment decisions for elderly cancer patients by including their preferences and performing an assessment.


- candidate number27723
- NTR NumberNTR6660
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR8-aug-2017
- Secondary IDsRUG 2013-6444 KWF
- Public TitleImproving treatment decisions for elderly cancer patients by including their preferences and performing an assessment.
- Scientific Title[provisional] Improving shared treatment decision-making for onco-geriatric patients through a tailored, multidisciplinary approach including patient preferences and geriatric assessment.
- ACRONYMn/a
- hypothesisThe majority of newly diagnosed cancer patients are >65 years of age. Elderly patients are more vulnerable than younger ones, due to comorbidities and frailty. Their treatment goals and preferences may also differ greatly. This study uses a stepwise approach to investigate decision-making, comparing tumour board decisions to treatment advice by a multidisciplinary onco-geriatric team meeting.
- Healt Condition(s) or Problem(s) studiedCancer, Older adults, Frailty, Patient preference
- Inclusion criteriaage >69 years; (suspicion of) solid tumour; referred to hospital for treatment; Dutch speaking
- Exclusion criteriano malignancy; non-solid malignancy; Non-Dutch speaking
- mec approval receivedno
- multicenter trialno
- randomisedno
- groupFactorial
- TypeSingle arm
- Studytypeobservational
- planned startdate 1-sep-2014
- planned closingdate1-jan-2018
- Target number of participants250
- InterventionsGeriatric Assessment including Time Up and Go (TUG), Groningen Activity Restriction Scale (GARS), Groningen Frailty Indixcator (GFI) EORTC QLQ-c30 and eld14; Letterfluency Test, Charlson comorbidity index (CCI). Patient preference discussion and prioritisation using Options Tool, nurse-led interview.
- Primary outcomeChange in treatment advice; Geriatric assessment outcomes; Process of inclusion and decision-making
- Secondary outcome(Improved) outcome; Patient satisfaction
- TimepointsGeriatric assessment + patient preferences + interview: upon inclusion.

Multidisciplinary onco-geriatric team meeting + patient discussion: up to 1 week after inclusion.

Follow-up interview, GARS, EORTC-QLQ-c30 and EORTC-QLQ-eld14: >6 months post-treatment
- Trial web siten/a
- statusinclusion stopped: follow-up
- CONTACT FOR PUBLIC QUERIES B.L. Leeuwen, van
- CONTACT for SCIENTIFIC QUERIES B.L. Leeuwen, van
- Sponsor/Initiator University Medical Center Groningen (UMCG)
- Funding
(Source(s) of Monetary or Material Support)
KWF Kankerbestrijding
- Publicationsn/a
- Brief summaryIn this study, we aim to include 250 onco-geriatric patients. They undergo a Geriatric Assessment and are interviewed by trained oncology nurses. They are asked to state their treatment goals and preferences using a decision tool. Following inclusion, patients are discussed during a dedicated onco-geriatric multidisciplinary team meeting and a treatment advice is given to their treating consultant based on assessment and interview outcomes. Follow-up takes place 6 months post-treatment.
- Main changes (audit trail)
- RECORD8-aug-2017 - 8-sep-2017


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl